Overview Dividends

(ACLS) Axcelis Technologies - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0545402085

Ion Implanters, Drying

ACLS EPS (Earnings per Share)

EPS Growth (3Y CAGR): -2.46%
EPS Trend (3Y Correlation): -39.3%

ACLS Revenue

Revenue Growth (3Y CAGR): -5.78%
Revenue Trend (3Y Correlation): -50.2%

Description: ACLS Axcelis Technologies

Axcelis Technologies Inc (NASDAQ:ACLS) is a US-based company operating in the Semiconductor Materials & Equipment sub-industry. To evaluate its investment potential, we need to deconstruct its financial performance and identify key drivers.

The companys Income Tax Expense is a critical component of its financial statements, influencing its Net Income and ultimately, its Earnings Per Share (EPS). A thorough analysis of the yearly Income Tax Expense can reveal trends and anomalies that may impact ACLSs valuation.

Key Performance Indicators (KPIs) to monitor include the companys tax rate, EPS growth, and Return on Equity (RoE), currently standing at 18.02%. The Price-to-Earnings (P/E) ratio is 12.98, suggesting a relatively reasonable valuation compared to its earnings. The Forward P/E of 14.18 indicates expected earnings growth.

Economic drivers influencing ACLSs performance include the demand for semiconductor equipment, driven by the growth of the global semiconductor industry, advancements in technology, and the increasing need for miniaturization and performance enhancements. The companys Market Capitalization of $2.277 billion USD is a relevant metric to assess its size and market influence.

To further analyze ACLSs potential, we should examine its revenue growth, gross margin, and operating expenses, as well as the competitive landscape and industry trends. By identifying leverage points and designing targeted interventions, we can optimize our investment strategy.

ACLS Stock Overview

Market Cap in USD	2,501m
Sub-Industry	Semiconductor Materials & Equipment
IPO / Inception	2000-07-11

ACLS Stock Ratings

Growth Rating	16.6%
Fundamental	65.6%
Dividend Rating	-
Return 12m vs S&P 500	-23.5%
Analyst Rating	3.57 of 5

ACLS Dividends

Currently no dividends paid

ACLS Growth Ratios

Growth Correlation 3m	87.4%
Growth Correlation 12m	-30.2%
Growth Correlation 5y	58.7%
CAGR 5y	13.69%
CAGR/Max DD 3y	0.17
CAGR/Mean DD 3y	0.35
Sharpe Ratio 12m	-0.64
Alpha	0.02
Beta	0.905
Volatility	43.41%
Current Volume	572.3k
Average Volume 20d	385.8k
Stop Loss	86.6 (-3.6%)
Signal	1.61

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (158.5m TTM) > 0 and > 6% of Revenue (6% = 53.8m TTM)

FCFTA 0.10 (>2.0%) and ΔFCFTA -2.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 99.03% (prev 75.05%; Δ 23.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.10 (>3.0%) and CFO 138.1m <= Net Income 158.5m (YES >=105%, WARN >=100%)

Net Debt (-130.6m) to EBITDA (204.6m) ratio: -0.64 <= 3.0 (WARN <= 3.5)

Current Ratio 6.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (32.1m) change vs 12m ago -2.04% (target <= -2.0% for YES)

Gross Margin 44.90% (prev 44.63%; Δ 0.27pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 68.62% (prev 86.27%; Δ -17.65pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 34.11 (EBITDA TTM 204.6m / Interest Expense TTM 5.50m) >= 6 (WARN >= 3)

Altman Z'' 8.26

(A) 0.67 = (Total Current Assets 1.06b - Total Current Liabilities 177.1m) / Total Assets 1.32b

(B) 0.37 = Retained Earnings (Balance) 487.2m / Total Assets 1.32b

(D) 1.62 = Book Value of Equity 486.7m / Total Liabilities 301.1m

Total Rating: 8.26 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 65.64

1. Piotroski 4.50pt = -0.50

2. FCF Yield 6.26% = 3.13

3. FCF Margin 14.52% = 3.63

4. Debt/Equity 0.12 = 2.49

5. Debt/Ebitda 0.61 = 2.22

6. ROIC - WACC (= 7.27)% = 9.09

7. RoE 15.70% = 1.31

8. Rev. Trend -50.23% = -3.77

9. EPS Trend -39.26% = -1.96

What is the price of ACLS shares?

As of September 17, 2025, the stock is trading at USD 89.81 with a total of 572,285 shares traded.
Over the past week, the price has changed by +8.10%, over one month by +11.25%, over three months by +30.23% and over the past year by -9.15%.

Is Axcelis Technologies a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Axcelis Technologies (NASDAQ:ACLS) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 65.64 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACLS is around 84.97 USD . This means that ACLS is currently overvalued and has a potential downside of -5.39%.

Is ACLS a buy, sell or hold?

Axcelis Technologies has received a consensus analysts rating of 3.57. Therefor, it is recommend to hold ACLS.

Strong Buy: 2
Buy: 0
Hold: 5
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ACLS price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	85.5	-4.8%
Analysts Target Price	85.5	-4.8%
ValueRay Target Price	95.1	5.8%

Last update: 2025-09-03 04:30

ACLS Fundamental Data Overview

Market Cap USD = 2.50b (2.50b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 549.8m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 16.2449
P/E Forward = 14.9254
P/S = 2.791
P/B = 2.4597
P/EG = 1.23
Beta = 1.574
Revenue TTM = 896.1m USD
EBIT TTM = 187.6m USD
EBITDA TTM = 204.6m USD
Long Term Debt = 124.0m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.44m USD (from shortTermDebt, last quarter)
Debt = 125.4m USD (Calculated: Short Term 1.44m + Long Term 124.0m)
Net Debt = -130.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.08b USD (2.50b + Debt 125.4m - CCE 549.8m)
Interest Coverage Ratio = 34.11 (Ebit TTM 187.6m / Interest Expense TTM 5.50m)
FCF Yield = 6.26% (FCF TTM 130.1m / Enterprise Value 2.08b)
FCF Margin = 14.52% (FCF TTM 130.1m / Revenue TTM 896.1m)
Net Margin = 17.69% (Net Income TTM 158.5m / Revenue TTM 896.1m)
Gross Margin = 44.90% ((Revenue TTM 896.1m - Cost of Revenue TTM 493.8m) / Revenue TTM)
Tobins Q-Ratio = 4.27 (Enterprise Value 2.08b / Book Value Of Equity 486.7m)
Interest Expense / Debt = 1.08% (Interest Expense 1.35m / Debt 125.4m)
Taxrate = 12.72% (29.3m / 230.3m)
NOPAT = 163.7m (EBIT 187.6m * (1 - 12.72%))
Current Ratio = 6.01 (Total Current Assets 1.06b / Total Current Liabilities 177.1m)
Debt / Equity = 0.12 (Debt 125.4m / last Quarter total Stockholder Equity 1.02b)
Debt / EBITDA = 0.61 (Net Debt -130.6m / EBITDA 204.6m)
Debt / FCF = 0.96 (Debt 125.4m / FCF TTM 130.1m)
Total Stockholder Equity = 1.01b (last 4 quarters mean)
RoA = 11.97% (Net Income 158.5m, Total Assets 1.32b )
RoE = 15.70% (Net Income TTM 158.5m / Total Stockholder Equity 1.01b)
RoCE = 16.55% (Ebit 187.6m / (Equity 1.01b + L.T.Debt 124.0m))
RoIC = 16.22% (NOPAT 163.7m / Invested Capital 1.01b)
WACC = 8.95% (E(2.50b)/V(2.63b) * Re(9.35%)) + (D(125.4m)/V(2.63b) * Rd(1.08%) * (1-Tc(0.13)))
Shares Correlation 3-Years: -96.97 | Cagr: -0.36%
Discount Rate = 9.35% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 73.15% ; FCFE base≈139.2m ; Y1≈135.2m ; Y5≈135.3m
Fair Price DCF = 61.06 (DCF Value 1.92b / Shares Outstanding 31.4m; 5y FCF grow -4.01% → 3.0% )
EPS Correlation: -39.26 | EPS CAGR: -2.46% | SUE: 2.26 | # QB: 3
Revenue Correlation: -50.23 | Revenue CAGR: -5.78%

Additional Sources for ACLS Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle